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Abstract 
Opioid addiction and abuse has become a nationwide epidemic in America. Chief among the states where this behavior 
is most pervasive is North Carolina. Current statistics reveal that not only are addiction, abuse, and untimely deaths 
owing to overdose (especially from heroin use) are found in urban areas, but these behaviors are also pervasive in rural 
areas of the state where health experts and criminal justice officials struggle with the challenges of addressing public 
health and criminal justice consequences that come with drug addiction and abuse such as treatment, prevention, and 
punishments, respectively. Unlike urban areas that often have adequate resources to address these concerns, this is not 
the case in rural areas that struggle with more addicts and offenders than resources to manage this current crisis. 
Because of the complexity of the opioid crisis and many of the past lessons learned from the crack cocaine epidemic of 
the 1980s, we believe that society can more effectively address the new opioid epidemic by relying on both criminal 
justice as well as public health strategies. 
Keywords: criminal justice approach, epidemic, opioid crisis, public health approach, strain theory 
1. Introduction 
Health experts and criminal justice officials report that within the past two decades, an opioid epidemic has spread 
across the United States causing an increase in negative health concerns as well as spikes in the crime rate 
(ManchiKanti et al., 2012; Dasgupta et al., 2014; Ford and Dulaney, 2013; Townes, 2016). Some drug experts attribute 
this increase to the prevalence of chronic pain that has manifested in drug addiction, while others see it as a problem 
that rests with the liberalization of laws created by state medical boards that proscribe opioids for treating chronic 
non-cancerous pain (ManchiKanti et al., 2012; Dasgupta et al., 2014). Moreover, in its 2010 report, the National Survey 
on Drug Use and Health revealed that an estimated 22.6 million Americans age 12 or older were either currently using 
illicit drugs or had done so in the past month. The survey also showed that an alarming number of Americans abuse pain 
relievers, as well as receive drugs from someone other than a health care provider. Health officials argue the opioid 
epidemic has reached the point of a national crisis since statistics show that in 2011, doctors wrote an estimated 136.7 
million prescriptions for therapeutic opioids such as hydrocodone. They also wrote over 238 million prescriptions for 
other narcotic analgesics (ManchiKanti et al., 2012; Also see Hirschi et al., 2014). Similarly, Hudson (2016) reports that 
each day in the U.S., an estimated 80 people die due to overdosing on opioids. At the same time, criminal justice 
officials report an increase in numbers of opioid related deaths contending that they outnumber deaths from suicides and 
motor vehicle crashes, or deaths from the combined use of cocaine and heroin. They also find that when opioid users 
cannot get enough prescription drugs for pain management, many turn to crime to get the money to buy drugs on the 
street, typically in the form of stolen opioids such as oxycodone or Vicodin. Experts also report that there has been an 
increase in heroin use to self-medicate pain. Surprisingly, in some jurisdictions around the country, especially North 
Carolina, many law enforcement officers believe addicts would be better served by being taken to treatment centers 
rather than jail (see Townes, 2016).    
Health officials argue that opioids are agents that produce their biological effects by binding to opioid receptors. Their 
primary clinical use is to treat and prevent pain. Pain is transmitted from neuron to neuron and travels to different parts 
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of the spinal cord and brain. Neurotransmitters are the molecules that are released from nerve terminals and transmit 
pain signals. When opioids are administered to relieve pain, they inhibit the release of neurotransmitters. Katzung 
(2004), provides that some major opioid analgesics include: morphine, hydromorphone, oxymorphone, methadone, 
mependine, fentanyl, sufentanil, alfentanil, levorphonol, codeine, hydrocodone, oxycodone, propoxyphene, 
pentazoncine, nalbuphine, buprenorphine, and butorphanol. While any of these opioids can be dangerous and pose 
serious health consequences when abused, the purpose of this paper is to focus on opioid addiction, especially heroin 
and its abuse in rural North Carolina. As such, this paper will be divided into four parts. Part One presents opioid abuse 
in rural North Carolina. Part Two offers the strain theory to reveal how and why users abuse opioids. Part three 
discusses public health approaches to the opioid epidemic. Part four presents criminal justice approaches to the opioid 
epidemic. In the end, we argue that a blended approach from the criminal justice and public health systems can 
significantly reduce the opioid epidemic. 
2. Opioid Abuse in Rural North Carolina 
Recent drug reports show that there has been a 400% increase in opioid medication deaths in North Carolina that 
spanned from 1999 to 2012. Despite this staggering statistic, Townes (2016) reports that the numbers are now higher 
revealing that from 2010 to 2014, heroin-related deaths in North Carolina skyrocketed by 565%. Research conducted by 
Dasgupta and colleagues (2014), find that within the past two decades, there has been a societal transition from 
prescription opioids to heroin which accounts for most overdose deaths. More specifically, they report that from 2007 to 
2013, there were 4,787 opioid related deaths, 455 involved heroin, 4,332 involved prescriptions, and 44 involved a 
combination of both. In the end, their investigation revealed a gradual six-year shift towards heroin deaths. Nevertheless, 
some health professionals and law enforcement officials argue many deaths may be linked to the stigma attached to 
being a drug user and how it prevents addicts from seeking medical assistance. Moreover, Townes (2016) posits that 
criminalizing addicts for crimes they commit to buy drugs, do not prevent the behavior. In fact, in rural North Carolina, 
especially in Nash County, police officers express that arresting some drug offenders is not the sole answer, o r the best 
response to these offenders. For example, the Nashville Police Chief introduced the HOPE initiative that offers 
treatment and counseling to heroin users who turn themselves in to police departments. Furthermore, policymakers have 
also gotten involved by drafting North Carolina’s Good Samaritan legislation or Senate Bill 20 that deregulates the use 
of Naloxone and provides limited immunity to some drug addicted offenders who ask for medical assistance if they 
believe they or someone known to them may overdose on opioids.  
Health experts report that the opioid epidemic is not only found in urban cities of North Carolina in places such as 
Charlotte, Raleigh, and Wilmington (the latter city has been cited as having the highest amount of opioid abuse in the 
nation), but rather, it is also pronounced in rural areas such as in Nash, Wilkes, and Wilson counties (Sisk, 2016). In fact, 
the same experts argue that no community in the state has shown itself to be immune from opioid addiction, abuse, and 
the devastation that comes along with it (Stephen, 2016; Hudson, 2016) including overdose deaths (most from 
prescription pain killers, but many from heroin use), increase in Hepatitis B and C cases, and an increase in crime 
arrests to procure monies to defray the cost of illegal drugs such as heroin, meth, and other opioids (AAFD News, 2014; 
Dasgupta, 2014). Further, Sisk (2016), reports that from 1999 to 2003, Nash County had only six overdose deaths and 
Wilson County had only four overdose deaths. However, the numbers vastly increased from 2010 to 2014, where the 
number of deaths from opioid overdose climbed to 27 and 22 for Nash and Wilson, respectively. Some reports reveal 
that rural law enforcement officers across the nation are confiscating heroin found on many suspects during arrest (Sisk, 
2016).  
In a recent survey that compiled the top 25 cities across the country with the highest rate of opioid abuse, four cities in 
North Carolina featured prominently in those statistics. For example, the survey revealed that Hickory, NC ranked fifth 
at 9.9 percent, Jacksonville, NC ranked 12th at 8.2 percent, and Fayetteville, NC ranked 18th at 7.9 percent, respectively. 
Wilmington, NC ranked number one. This finding is shocking to drug experts and others in public health since many 
believe opioid abuse in general, but heroin use and abuse in particular, is a big city problem thought to be commonly 
found in places such as New York City, Los Angeles, Chicago, and Miami (Sisk, 2016). Nevertheless, the survey also 
revealed that 22 of the top 25 cities were in the south. Consequently, many health experts now believe that opioids 
abusers are more likely to be from southern states. What is more interesting about the increase in opioid use is the type 
of people who are using these drugs. For example, a report by the Centers and Disease Control and Prevention (CDC), 
revealed that in recent years, the most extreme use of heroin has been found among groups that have not historically 
been known for using illicit drugs. They include women, those with private insurance, and with higher income (Sisk, 
2016). Similarly, Torpy (2015) reported that there has been growth in the number of opioids related deaths among 
middle-aged white males in rural Georgia and other areas of the country who struggle with the changing economy and 
providing for their families in the future. Moreover, CDC data from 2012 revealed that the rate of opioid deaths in 
nonurban areas was 45 percent higher than those that occurred in urban areas around the nation (Sisk, 2016).   
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Some drug experts contend that the devastation of opioid addiction has been more pronounced in rural North Carolina 
compared to urban settings because small towns are less prepared to address the influx of drugs and the negative health 
consequences that follow. More specifically, health experts warn that rural towns lack resources needed for prevention 
and treatment programs that are found in urban cities such as New York, Los Angeles, Chicago, and Miami where there 
is more money for treatment and prevention programs. As such, vitally needed treatment options are often limited and 
not accessible to local residents. This, in itself, worsens the problem in rural areas since drug addicts are likely to 
continue using and engaging in crime to support their habit. Moreover, Galea and colleagues (2003) argue that access, 
or the lack thereof to health care, poverty, and unemployment, painful conditions, risky behavior and other broader 
societal determinants also influence heroin use.  
3. Robert Agnew’s General Strain Theory and the Use of Opioids 
Robert Agnew‘s General Strain Theory can be used to explain the effects of strain and why people use and become 
addicted to opioids. Agnew’s theory provides explanatory power that addresses individual behavior. In fact , Agnew 
explains why people, regardless of social class, experience strain that could lead to crime. His view of criminal activity 
examines all segments of society, rather than targeting crimes solely committed by lower-class people (Agnew, 1992). 
Agnew argues that criminality is a manifestation of negative experiences and emotions caused by personal strain. These 
experiences often lead to feelings of anger, frustration, disappointment, depression, or fear that develop as a result of 
destructive relationships. Agnew presents four categories of negative emotions that include: the failure to achieve 
positively valued goals; disjunctions of expectations and achievements; removal of positively valued stimuli; and 
presentation of negative stimuli (Agnew, 1992). First, a failure to achieve positively valued goals occurs when one’s 
structural means do not allow the acquisition of cultural goals. This occurs when people desire economic and material 
attainment, but lack legitimate resources to obtain them. According to the theory, this leads to strain and negative 
emotions. Second, the disjunction of expectations and achievement can be experienced by anyone regardless of 
economic status. For example, one can experience strain if he or she cannot get ahead or perceives others are doing 
better or achieving their goals (especially with respect to race, ethnicity, or economic background). Those who 
experience strain, may lash out, acquire things illegitimately, or seek alternatives to cope with the situation. Third, the 
removal of positively valued stimuli creates strain after something valued is removed, taken, or lost. Consequently, one 
may commit crimes to maintain his or her standard of living. Finally, the presentation of negative stimuli creates strain 
when one experiences victimization, punishment, abuse (e.g., drug dependency), failure, or any behavior believed an 
affront to one’s dignity (Agnew, 1992).  
Since every negative emotion that Agnew discussed in his theory is not needed to explain the increase in opioid use  and 
addiction, this section primarily focuses on the failure to achieve positively valued goals, the disjuncture of expectations 
and achievements, and the presentation of negative stimuli (e.g., primarily opioid prescriptions or illegal drugs that 
manifest into addiction). These components of Agnew’s theory are economic, psychological, and physical. They can be 
used to explain why people from all socioeconomic backgrounds use drugs in general, and opioids, in particular. 
Accordingly, the theory holds that if a person is either unable to attain economic prosperity, fails to meet financial 
expectations, or is dependent on prescription or illegal drugs, he or she will experience strain that could lead to crime. 
For example, if the job market does not accommodate the demands of the labor force, those who desire work will 
experience strain if they desire a certain standard of living. Moreover, those who desire to rise above their economic 
station, or people who become addicted to drugs will experience negative emotions or develop a need to acquire drugs. 
Consequently, these frustrations could steer some into drug use (more recently opioids) to cope with the realization that 
they are blocked from opportunities to support themselves as well as meet the needs of their families.  
General strain theory argues that criminal behavior is a reaction to harmful emotions such as anger, depression, and 
anxiety, stemming from negative relationships with others including “noxious” circumstances, such as constant pain 
that could prevent some from obtaining desired goals (Agnew, 1992). It is the negative effect or primarily depression 
that can lead to avoidance or mediating criminal “internalizing behavior” including substance use (Slocum, 2010). 
Miller and Lynam’s (2001) research revealed personality traits, such as “negative emotionality,” caused some to 
experience negative emotions and “breakdown under stress” or strain. Similarly, Agnew (2006) addressed the 
perceptions of stressful events and how people’s reaction to them could lead to a cycle of strain and criminal behavior. 
As stressful events that precipitate and result from criminal behavior, including substance use, accumulate, stressor 
amplification may occur. Moreover, Agnew and colleagues (2002) reported a relationship existed between the strain of 
being economically disadvantaged (see also Schroeder et al., 2011), and certain types of criminal behavior. This is 
particularly true for poor, minority women with children. Slocum (2010) added another critical factor, the exper ience of 
stress over a portion of the life cycle, or the duration of strain, which she referred to as stress proliferation, leading to 
chronic strain (Perlin et al., 1981) that could result in stable and continued use of substances. In effect, there may be 
“life trajectories” set in motion by stressors and maintained by strain including the initial and continued use of 
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substances (Slocum, 2010).  
In their investigation, Schroeder and colleagues (2011) examined poor health conditions including pain which may  
cause strain that prohibits people of all ages from achieving their goals. They found that pain not only prohibits the 
attainment of positive goals, but it also eliminates existing positive activities, such as going out in the community, 
performing work, participating in sports, attending educational institutions, and essential aspects of parenting which 
invariably leads to psychological distress and frustration (p.22). Despite this, Jang (2007) finds that while men 
disproportionately respond to strain with anger, females who experience high levels of strain report suffering from 
depression and anxiety. Along with these, men and women may also experience sadness, hopelessness, fear, and worry 
(Schroeder et al., 2011). Any single or a combination of these negative emotions could be a situational event, such as a 
financial crisis, that triggers criminal coping such as substance abuse (p.29).  
Recent research reveals that strain resulting in substance abuse has not been ethnically or culturally exclusive. In fact, a 
study by Case and Deaton (2015), reveals that from 1999-2013, there has been a substantial increase in the morbidity of 
white non-Hispanic Americans, particularly between the ages of 45-54. Likewise, the Centers for Disease Control and 
Prevention (CDC) (2016), reports the same increase in overdoses among an even younger group with increased 
mortality found among those between the ages of 25-54. More specifically, it reveals that from 2000 to 2014, nearly a 
half million people died from drug overdose which amounts to 78 Americans dying each day owing to opioid overdose 
(CDC, 2016b). Additionally, health officials believe the opioids related to these deaths were mostly obtained by 
prescriptions since there has been a fourfold increase in the amount of prescriptions for opioids (especially Methadone, 
Oxycodone, and Hydrocodone) sold since 1999. The CDC also provides that the negative consequences of 
over-prescribing drugs go beyond overdose. For example, health experts reveal that in 2014, nearly 2 million Americans 
were reported to have abused or were addicted to prescription opioids, and almost 1,000 persons per day were treated in 
emergency care for prescription opioid misuse (CDC, 2016a). Both addiction and the need for emergency care are 
considered sources of strain. Furthermore, some scholars attribute this increase to the rise in strain indicated in “lowered 
self-reported health and mental health, increased reports of pain, and greater difficulties with daily living” (Case and 
Deaton, 2015). Moreover, Case and Deaton report that drug poisoning (accidental or unintentional) is one of the three 
leading factors associated with the rise in mortality among white non-Hispanics, along with suicide and liver disease. 
They report that both suicide and drug poisoning increases were greater among those with the least education. They also 
found that the mortality rate from drug poisoning underwent a fourfold increase. Moreover, they revealed the link 
between decreased self-assessed health and increased reports of pain associated with all body regions: neck pain, face 
pain, joint pain, and sciatica. Research by Case and Deaton showed that among those who experienced increased 
difficulty with activities of daily living, many also reported significant levels of psychological distress or strain. While 
citing the increased availability of opioids as paralleling the increased rate of mortality, Case and Deaton (2015) 
revealed that it is difficult to determine which came first, the rise in opioid abuse or a rise in pain, as  long-term opioid 
use has been found to exacerbate pain for some. 
In their study, Stogner and Gibson (2010) examined a health strain hypothesis involving the physical ailments that lead 
to strain and criminal behavior, such as substance use and the inability to access appropriate healthcare for treating the 
source of pain or illness, as well as the substance abuse or addiction (McCabe & Wahler, 2016). They argued that this 
leads to increased strain and forces those needing healthcare to act criminally when barred from legal medical assistance. 
Opioids taken from the pharmacy and sold on the street is a public health issue itself (Dasgupta et al. 2013). However, it 
may be the only source of pain alleviation that some people have access to, which means that they could face more risks: 
potentially dangerously modified drugs, absence of medical monitoring, and association with drug traffickers. These 
often lead to increased strain. 
4. Public Health Approaches to the Opioid Epidemic 
The dramatic rise in opioid pain relievers (OPR) caused by prescription and illegal means has led to an unprecedented 
increase in opioid overdoses. Health officials as well as criminal justice experts have labeled this epidemic a national 
crisis. In fact, in 2013, the CDC added the prevention of mortality from opioids to the list of public health challenges. 
Among the list, prescription drug abuse and overdose ranked second among the five top health threats for 2014 (CDC, 
2014). Ironically, in 1995, the American Pain Society launched a campaign encouraging physicians to increase the use 
of opioids for non-cancer pain treatment (Campbell, 1996). Moreover, to respond to some physicians’ reluctance to treat 
pain with opioids, opioid manufacturers published research citing low risk for addiction (Portenoy, 1996). 
Although the highest numbers of opioid related deaths occur among people between the ages of 45-54, the greatest 
increase in opioid related mortality is found among persons between the ages of 55-64 (Kolodny et al., 2015). However, 
the nonmedical use of OPRs is more prevalent among people between the ages 15-24 (SAMHSA, 2009). Despite this, 
opioid overdose and deaths occur among adult medical OPR users more frequently than non-medical young users 
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(Kolodny et al., 2015). Because of the age of users and that overdose is high among both medical and non-medical OPR 
users, public health strategies must employ a variety of formats. To that end, Kolodny and colleagues (2015) argue that 
opioid overdose prevention efforts should take the form of three categories: primary, secondary, and tertiary preventions. 
First, primary prevention must target overdose cases caused by the medical use of OPRs, as well as those linked to 
non-medical use. The most crucial point of prevention for medical related cases must target the prescribing physician. 
This requires that physicians are informed of the risks associated with OPRs and that they must follow rigid guidelines 
when prescribing opioids. Health care experts argue that federal and state agencies must also participate in these efforts. 
In fact, the Federal Drug Administration (FDA) released a revised Risk Evaluation and Mitigation Strategies (REMS) 
for prescribing extended-release and long-acting opioids in 2014. Though the FDA was asked to require all physicians 
who prescribe medication to undergo mandatory training, it relented, and instead ordered that manufacturers of opioid 
medications solely bear responsibility for making education programs available to prescribers for continuing education 
credits and to make educational information accessible to patients (FDA, 2014). The FDA also advised that this protocol 
receive periodic evaluation. Critics of the FDA effort report that some of the education received by OPR prescribers 
place the OPRs in a positive light and may encourage continued prescribing, rather than curbing it by providing 
accurate information about OPR risks (FDA, 2011). 
Research reveals that several states support the DEA’s effort to pass laws enforcing penalties on “pill mills.” These 
efforts allow physicians to examine patients’ pharmacy activity for controlled substances. In Washington State, the law 
mandates the use of evidence for tracking a patient pain level and functional status while being prescribed OPRs (Okie, 
2010). Additionally, in March 2016, the CDC released the Guideline for Prescribing Opioids for Chronic Pain—United 
States, 2016. The difference between the old and new guidelines were threefold: First, the dosage recommendations for 
exercising caution are lower,” because small doses are also risky; Second, prescribers are urged to use “safety 
precautions” with every patient and not only those considered high risk, and prescribers are encouraged to use state 
prescription drug monitoring programs. Third, “more specific recommendations [are made] on monitoring and 
discontinuing opioids when risks and harms outweigh benefits” (CDC, 2016b). Additionally, educational webinar series 
and physicians’ use of non-pharmacologic methods of treating chronic pain were also recommended. For patients, the 
guidelines provide information about the risk of abuse and addiction, as well as information on the nature of OPRs. The 
state of New York has implemented additional guidelines to address opioid abuse. For example, New York released 
emergency room OPR guidelines in 2013 (New York City Department of Health and Mental Hygiene, 2013). More 
specifically, it introduced a two-prong primary prevention strategy for non-medical use of OPRs in an effort to reduce 
prescribing OPRs to institute prescription drug “take back” opportunities whereby patients can safely return unused 
OPRs to keep them off the streets, prevent them from being smuggled as contraband into jails and prisons, and from 
being used by friends and family (Kolodny et al., 2015). 
Next, secondary prevention efforts are designed to screen conditions before they become dangerous issues, such as OPR 
abuse before it becomes OPR addiction (Kolodny et al., 2015). In the absence of effective screening tools and trained 
personnel working in primary care offices, prescription drug monitoring programs (PDMPs) have become a viable 
option. PDMPs are state operated electronic databases that monitor prescribed controlled substances (CDC, 2016a). 
They attempt to detect patients who are doctor shopping or patients who get prescriptions from several doctors by two 
mechanisms: physicians and pharmacists can consult the PDMP before prescribing or, they may practice in a state that 
sends out unsolicited reports identifying patients who regularly seek drugs (Kolodny et al., 2015). Another benefit of 
PDMPs is that they prevent drugs from being diverted to illegal sales (CDC, 2016a). Some states have made PDMPs 
mandatory, while others have recommended their use; prescribers can enter data into the system in real-time, thus 
maximizing its effectiveness; they can be utilized by public health entities to track the use of OPRs to inform 
intervention practices; and they can be made easily accessible and user-friendly for prescribers (CDC, 2016a). 
Third, tertiary prevention measures entail treatment, including harm reduction practices. However, the persons needing 
this treatment the most, primarily lower-income persons who lack insurance have had the least access to it. Those who 
are most addictive are likely to experience greater difficulty maintaining or finding employment. Therefore, their 
treatment will be severely limited, unless they live in a state that provides Medicaid expansion (McCabe & Wahler, 
2016). Treatment for addiction should also cover co-occurring medical or mental health disorders. However, the health 
system is currently fragmented and makes holistic, “chronic disease management” costly and unavailable to those 
lacking healthcare insurance (McCabe & Wahler, 2016, p. 228). According to SAMHSA (2013), the 2012 National 
Survey on Drug Use and Health revealed that nearly 2.1 million Americans were addicted to OPRs with another 
467,000 addicted to heroin. Despite this grim figure, some argue the number of persons experiencing opioid addiction 
might exceed 5 million (Kolodny et al., 2015). Treatment may consist of detox, long-term inpatient and outpatient, 
psycho-social education, self-help group attendance, and pharmacotherapies such as methadone maintenance and 
buprenorphine maintenance (569). Kolodny and colleagues also recommend access to Naloxone, the opioid overdose 
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antidote preventing opioid overdose deaths, as a tertiary prevention method. 
Another tertiary measure to prevent opioid addiction is stricter regulations in drug marketing. For example, under the 
Food, Drug, and Cosmetics Act, the FDA is responsible for approving drug marketing material when it is disseminated. 
However, it is difficult to measure accountability. In the past few years, pharmaceutical companies have faced criticisms 
for marketing tactics that promoted the use of opioids. Moreover, Chicago and two counties in California are suing five 
drug companies for "aggressive marketing" that “has fueled an epidemic of addiction and cost taxpayers millions of 
dollars in insurance claims and other health care costs” (Schwartz, 2014). Recently, Pfizer agreed to modify its 
marketing of opioids “to disclose in its promotional material that narcotic painkillers carry serious risk of addiction even 
when used properly. Additionally, it promised not to promote opioids for unapproved, "off-label" uses such as long-term 
back pain” (Pfizer agrees to truth in opioid marketing, 2016). Critiques argue that Pfizer was likely reacting to the 
FDA’s newest guidelines on labeling, for immediate-release (IR) opioid pain medications, which included the 
requirement of a “new boxed warning about the serious risks of misuse, abuse, addiction, overdose and death,” among 
other safety labeling changes for all opioid medications. 
5. Criminal Justice Approaches to the Opioid Epidemic 
Illegal drug use and their distribution are criminal justice issues since they have serious consequences often diminishing 
the quality of life of law-abiding community residents, as well as contributing to large numbers of arrestees entering 
into the justice system. Many people believe that there is a nexus between the presence of drug users, addicts, and more 
crime. While this appears commonsensical, not everyone fully agrees. Stated differently, the relationship between drug 
use, addiction, and crime is well documented in the criminological literature, but some scholars and drug experts warn 
that a linear relationship may not exist (see Inciardi, 1981; McBride and McCoy, 2003; Bean, 2014; Schram and 
Tibbetts, 2014). Notwithstanding, communities that have a drug presence are typically places where one finds a high 
crime rate that includes: robberies, violent shootings, burglaries, deaths, and accidental overdoses. They are also places 
where sex work (from both male and female prostitutes) occurs whereby addicts often engage in unsafe and unprotected 
sexual behaviors to earn money needed to buy drugs. Despite this, Peak and Everett (2017) argue that an increasing 
problem now confronting society and the criminal justice system is the abuse of prescription painkillers. They provide 
that an estimated 100 million Americans or nearly a third of the U.S. population suffers from chronic pain and even 
more alarming is the fact that in an effort to provide relief, health care professionals write nearly 219 million opioid 
prescriptions annually (also see Calabresi, 2015).  
Because of lessons learned from the past war on drugs, experts and criminal justice officials are trying different 
approaches compared to those that were used in minority communities (e.g., disproportionately black and Latinos) 
during the mid-1980s and the early 1990s. For example, research conducted by Chappell and Maggard (2007) revealed 
that in their efforts to fight the war on drugs, states throughout the nation passed severe laws that handed down harsh 
sentences to offenders found in possession of crack or “rock” cocaine. They argued these laws overwhelmingly targeted 
the poor by imposing stringent punishment for possessing crack cocaine, while at the same time, giving substantially 
less punishment to middle and upper class white offenders who were in possession of large quantities of powdered 
cocaine. Moreover, many impoverished communities experienced living under a “police state” or police occupation 
followed by unprecedented numbers of arrests where tough mandatory sentences were routinely imposed. In fact, to 
address what many politicians, scholars, community residents, and organizers now believe were discriminatory drug 
laws, in 2010, President Barack Obama signed The Fair Sentencing Act to help decongest many of the nation’s 
overcrowded prisons, especially those housing offenders who were unfairly sentenced by disparate laws that targeted 
minority communities in general, and young black and Latino males, in particular. More specifically, the Act was 
designed to reduce the disparity in the amounts of powder cocaine and crack cocaine designed to trigger penalties in the 
federal system, namely mandatory minimum sentences that devastated and destabilized poor minority communities 
across the country (Messner & Rosenfeld, 2013). Notwithstanding, penologists argue the U.S. imprisons over 2.5 
million offenders, many of whom are confined because of drug violations and are viewed in many cases as the 
casualties of the drug war of the 80s and 90s (Hanser, 2017).  
Since past efforts used to fight the war on drugs resulted in racial profiling, unequal treatment, prison overcrowding, 
and the need to reform the justice system (including the implementation of community-based correctional initiatives to 
reduce prison overcrowding), criminal justice experts believe these efforts have informed the changing views regarding 
how the war on drugs should now be waged (see Peak and Everett, 2017). For example, critics of past practices and 
policies argue that an effective criminal justice response to the national drug crisis in general, but the use of opioids in 
particular, must go beyond simply arresting and charging addicts for drug offenses. To the point, Schram and Tibbetts 
(2014) argue that contemporary approaches to reduce opioid use are fourfold: interdiction strategies; eradication 
strategies; drug courts; and harm reduction. First, interdiction occurs when law enforcement agencies (e.g., local, state, 
and federal) engage in efforts to stop the flow of drug trafficking. Law enforcement experts contend that disrupting the 
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flow of illegal drugs (especially the distribution of opioids), is essential to combating the drug problem. They argue that 
this strategy is not simple since research reveals the steps involved in drug interdiction include: providing intelligence 
sharing, detection, distinguishing drug smuggling traffic from legitimate traffic, trafficking and or intercepting contacts, 
shifting primary responsibility between forces or actors, stopping activities (especially the f low of opioids), detention, 
arrest, seizure of suspects and evidence to gain a criminal conviction, and prosecution during criminal proceedings 
(Office of National Drug Control Policy, 2010). To have a chance of succeeding in interdiction efforts, in 1988, 
Congress passed the Anti-Drug Act which focused on reducing drug trafficking and production in the U.S. by 
facilitating cooperation between local, state, and federal law enforcement agencies in sharing information, intelligence, 
and coordinating strategies to prevent drug trafficking.  
The Anti-Drug Act created High Intensity Drug Trafficking Areas (HIDTA) program. More specifically, there are 
currently 28 programs in the U.S. that are located in counties throughout 46 states, the Virgin Islands, and the District of 
Columbia (Office of National Drug Control Policy, 2010; also see Schram and Tibbetts, 2014). HIDTA are believed to 
be effective because they employ multiagency investigations, interdiction, and prosecutions. They are also involved in 
prevention and treatment efforts (Office of National Drug Control Policy, n.d.). Research reveals that the Ohio area 
HIDTA encompasses eleven counties that include links to major drug source regions such as Chicago, Detroit, New 
York City, the Southwest Border, and Canada. It also found that many interstate highways are used to traffic illegal 
drugs throughout the region. Moreover, Ohio’s HIDTA reported that over the past 25 years, commercial truck 
trafficking has increased by 90% and is expected to increase by 60% by 2020. Furthermore, it revealed that because of 
the addictive nature, an increase in cocaine is likely to threaten the Ohio HIDTA area (Ohio High Intensity Drug 
Trafficking Area, 2009).      
Second, eradication is another strategy used to fight and reduce illegal opioids from entering the U.S. Gaines and 
Kappeler (2008) argue that while many drugs are manufactured in the US, heroin and other opioids are imported from 
Mexico, Afghanistan, Iran, Myanmar, Laos, and Thailand. Eradication focuses on destroying drugs, especially opium 
poppy, the coca bash, and cannabis plants (Farrell, 1999). Farrell provides that while there are four types of eradication 
techniques, namely: mechanical destruction, burning, chemical, and biological (e.g. genetic), the mechanical and 
chemical strategies are most often used. Criminal justice experts in general, and drug enforcement officials in particular, 
report that over the years, eradication efforts have been successful. In fact, the National Drug Intelligence Center (2008), 
reported that eradication efforts in Columbia to prevent the production of coca plants, resulted in an 8 percent decrease 
worldwide in 2007. Similarly, cocaine production in Peru has also declined owing to forced and voluntary eradication 
efforts. Within the U.S. borders, eradication efforts have also been successful. For example, the DEA reports that 
cannabis eradication and suppression programs are increasing in the western as well as eastern states. More specifically, 
these programs are appearing in cultivation states such as Hawaii, Tennessee, Kentucky, Washington, and West Virginia. 
The DEA also reports that to elude detection, drug traffickers have switched to indoor cultivation. Drug experts argue 
that indoor cultivation is more challenging to law enforcement officials since it is unseen and can be cultivated 
perennially. The DEA also reports that with states decriminalizing the use of marijuana for medical use and in some 
areas for recreational use, it is difficult to know the effects of eradication efforts, especially in light of states that are 
decriminalizing its use, while the federal government remains steadfast that the behavior violates federal law (National 
Drug Intelligence Center, 2009).   
Third, experts argue that because of the war on drugs, offenders clog the criminal justice system at every level and are 
expensive to process. To offset the influx, drug courts have been created. While initially introduced in the latter 1980s, 
as drug use and addiction increased, especially among opioid abusers, so too, has the need to create more drug courts 
for this special population of offenders (Lurigo, 2008). Drug courts are a popular strategy used to combat substance 
abuse issues, drug addiction, and its corresponding crime. They offer drug offenders an opportunity to participate in 
treatment and counseling programs or receive incarceration. While drug courts across the U.S. have different standards, 
they share some commonalities such as the duration of drug treatment programs (typically 12 to 24 months) and the 
components that participants experience. According to Gaines and Kappeler (2008), drug court treatment programs 
contain three phases. First, participants experience regular supervision, frequent meetings and drug testing. Second, they 
receive drug treatment and programs design to improve their life chances. These programs often include job training, 
life skills, and GED completion. In the third phase, participants are followed after completion of the program and are 
provided more job training skills. Gaines and Kappeler provide that as participants move through the three phases, they 
receive less supervision from program officials.      
Drug courts are believed to be cost-effective since they expedite case processing, provide outpatient treatment and 
support services (Harrell, 2003). They also save limited correctional dollars since they are an alternative to prison for 
many nonviolent offenders (Gottfredson, Najaka, & Kearley, 2003). They provide job placement and housing, 
mandatory drug testing and intensive court or probation supervision (Lurigio, 2008; also see Fox and Huddleston, 2003). 
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Unlike other criminal courts, these courts rely on the combined efforts of justice and treatment professionals to assist 
drug addicts with ending the downward spiral of addiction and crime (Fox and Huddleston, 2003). Moreover, 
Huddleston and colleagues (2008), argue that offenders identified as substance abusers are placed under judicial 
monitoring and community supervision and provided long-term treatment services. In these programs, offenders 
participate in drug treatment and testing, probation supervision, and report to scheduled status hearing before a judge 
(see Fox and Huddleston, 2003). Justice experts argue that there are advantages to participating in drug court ranging 
from having one’s charges missed or reduced, getting one’s substance abuse problem addressed, acquiring employment, 
and in some cases, retaining custody over one’s children (Cooper, 2007). Sechrest (2003) reported that drug courts are 
successful at reducing drug use among participants. In fact, one study found that drug court graduates were rearrested at 
a rate of 16.4% per year compared with a rate of 43.5% for nonparticipants for the same period (The White House, 
2007). Despite this, Wolfer (2006) contends there are disadvantages attached to these programs that include the pretest 
bias of awareness of scheduled urine tests allow participants to pass this phase of the program, and that the programs are 
viewed as unfair since they address individual needs and lack uniformity.   
Fourth, some drug experts advocate a harms reduction approach to prevent illegal opioid use calling for policies that 
incorporate a public health approach to reduce the harm associated with illegal drug use (McBride et al., 2009). These 
experts view drug use as a public health, rather than a criminal justice problem (Haden, 2004; MacMaster, 2004). The 
harms reduction approach is viewed by some as unconventional, unethical, and in some cases, its legality has been 
questioned (Burris et al., 1996). One example of a popular harms reduction program is needle exchange. It includes: 
providing sterile needles (e.g., needle exchange), outreach efforts, substituting opioids for methadone, and providing 
facilities for supervised injections. Experts argue that such programs allow drug users to receive treatment for medical 
and psychological help (Barkan, 2006). Needle exchanges are used since many people, as well as health officials are 
concerned about the pervasiveness and dangers associated with drug addicts sharing contaminated syringes or “dirty” 
needles. Therefore, these programs provide clean and unused syringes to intravenous drug users. Health officials and 
justice experts argue the approach is effective in reducing the spread of HIV, hepatitis B and C, and other viruses that 
could pose a threat to the community if needle sharing occurs. These programs also offer counseling and referrals to 
drug treatment programs (see Delgado, 2004). In fact, Duff (2010) reports that exchange programs make drug use safer 
and promote healthier behavior among addicts. Moreover, exchange programs provide educational materials that 
highlight the dangers linked to needle sharing and the spread of STD’s. They also supply bleach bottles, cotton swabs, 
skin ointment, and condoms.  
Regardless of the benefits of having needle exchange programs, some researchers have examined the legality of such 
programs and have expressed concerns over possible violations over existing drug paraphernalia laws. More specifical ly, 
there have been mounting concerns regarding the manufacture, possession, and distribution of drug paraphernalia. 
Researchers argue that these are illegal in 46 states and Washington, D.C. For example, Burris and colleagues (1996) 
conducted research that examined 49 needle exchange programs to determine whether they operated legally. Their study 
found that some of the programs (n=9) violated local laws and their participants risked being criminally prosecuted for 
violating drug paraphernalia laws. Moreover, several other programs (n=27) were either directly or indirectly authorized 
by state amendment or judicial interpretation of the law to be exempted from prosecution (Burris et al., 1996). They also 
found that the remaining programs (n=13) had not been challenged and reviewed by the courts, but claimed their 
legality on the basis of being found under state public health and drug laws.                   
6. Conclusion 
Because opioid addiction has reached the point of crisis in the U.S., effective responses will require that those 
addressing the issue rely on both criminal justice and public health strategies to reduce and treat the problem. As stated 
earlier, some sobering lessons learned from the crack epidemic of the 1980s and 1990s reveal that by treating the drug 
problem solely as a criminal justice issue instead of a health problem, it resulted in punitive measures with negative 
consequences, such as mandatory sentences, prison overcrowding, destabilization of minority communities, and a 
continued legacy of mistrust of police and the justice system. By viewing the current opioid epidemic as both a criminal 
justice and public health issue, it requires more than punishing drug users and offenders. It also requires recognizing the 
impact of opioid addiction and its byproducts that include a lack of productivity, absenteeism, lost wages, broken 
families, shattered lives, crime, spread of HIV/AIDS, excessive emergency room care, overdoses, untimely deaths, and 
others. Surely, these negative consequences go beyond criminal justice and therefore, cannot be adequately addressed 
by the agencies in the justice system (e.g., police, courts, corrections). Notwithstanding, Schneider (2000) contends that 
when the public’s health is threatened, society in general, and the government in particular, must respond with viable 
solutions. To that end, President Obama recently signed into law the Comprehensive Addiction and Recovery Act of 
2016 to address the opioid epidemic.  
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The Act has a sixfold purpose that enlists criminal justice and public health strategies. First, it provides prevention and 
education efforts to teenagers, parents, aging populations, and caregivers to prevent abuse of  amphetamines, opioids, 
and heroin. Second, it allocates resources to identify and treat incarcerated offenders who suffer addiction. Third, it 
increases the number of disposal sites for unwanted prescription medication. Fourth, it initiates an evidence based 
opioid and heroin treatment and intervention program to expand best practices throughout the nation. Fifth, it launches a 
medication assisted treatment and intervention demonstration program. Finally, it provides for strengthening 
prescription drug monitoring programs to help states monitor and track prescription drug diversion used to help at-risk 
individuals access service. While the Act alone is not meant to serve as a panacea, it defines opioid addiction as a health 
issue that requires a medical and healthcare approach that also extends to incarcerated offenders. Since millions of 
Americans suffer from opioid addiction, this federal effort along with state sponsored programs are essential steps in 
addressing this national crisis, especially since it allocates monies to rural states such as North Carolina which lacks 
needed resources to adequately combat addiction and provide treatment programs. Similarly to the Comprehensive 
Addiction and Recovery Act, we support the use of existing prevention strategies from both the criminal justice as well 
as the public health systems. We believe that a failure to do so would lead to failed criminal justice as well as public 
health policy that could prove counterproductive in addressing opioid addiction.  
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